ABO rs8176719: Understanding the Genetic Basis of Blood Type O

What each genotype means

What is rs8176719?

The variant rs8176719, often referred to in scientific literature as c.261delG, is a deletion of a single guanine nucleotide within the ABO gene. Located on the long arm of chromosome 9, this specific site is critical for the function of the ABO blood group system. When this nucleotide is deleted, it causes a frameshift in the genetic code, which alters the sequence of the resulting protein. This change leads to the production of a truncated, non-functional version of the glycosyltransferase enzyme. Because this enzyme is responsible for adding specific sugars to the surface of red blood cells to create A or B antigens, its absence results in the O blood type phenotype. This variant is the most significant genetic marker used to distinguish the O allele from the functional A and B alleles.

The Role of the ABO Gene

The ABO gene encodes glycosyltransferases, which are enzymes that catalyze the transfer of sugar molecules to proteins and lipids on the surface of cells. In the context of blood typing, these enzymes modify the H antigen found on red blood cells. The A allele produces an enzyme that adds N-acetylgalactosamine, while the B allele produces an enzyme that adds galactose. These modifications define the A and B blood types, respectively. When an individual carries the O allele—defined by the rs8176719 deletion—the resulting protein is inactive and cannot perform these modifications. Consequently, the H antigen remains unmodified, which is the hallmark of blood type O. Beyond blood typing, the ABO gene is involved in various metabolic and signaling pathways, and variations in this gene have been studied for their potential associations with susceptibility to certain infectious and cardiovascular conditions.

Research and Associations

Research has extensively linked rs8176719 to the determination of ABO blood groups, with strong evidence supporting its role as the primary driver of the O phenotype. Beyond basic blood typing, the GWAS Catalog and other studies have explored associations between this variant and various clinical traits, including venous thromboembolism, malaria susceptibility, and even responses to certain viral infections like COVID-19. It is important to note that while these statistical associations exist, they are often complex and influenced by environmental factors and other genetic modifiers. The evidence for these non-blood-type associations varies in strength, and many findings are subject to ongoing investigation. Readers should view these associations as population-level observations rather than individual medical predictions. Always consult with a healthcare professional to understand how your specific health history relates to your genetic profile.

What You Can and Cannot Do With This Information

Knowing your genotype for rs8176719 can provide insight into your inherited blood type, but it is not a substitute for clinical blood typing performed in a laboratory. While genetic testing can predict blood type with high accuracy, serological testing remains the gold standard for medical procedures like blood transfusions. You cannot use this information to diagnose yourself with any disease or to make independent medical decisions regarding your health. If you are interested in how your genetic background might influence your health or susceptibility to specific conditions, discuss this with your doctor or a genetic counselor. They can help interpret these findings within the context of your overall health and provide guidance on appropriate screenings or preventative measures. Never change or stop any medication based on genetic information without first consulting your clinician or pharmacist.

Frequently asked questions

Sources & further reading

Related variants in ABO